title: Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects.
abstract: OBJECTIVE
  To describe the potential for recurrence of group B streptococcal (GBS) infection in infants, using pulsed-field gel electrophoresis as an epidemiologic tool.
  
  
  METHODS
  Retrospective review of cases identified by laboratory records and review of the literature.
  
  
  METHODS
  Neonatal nurseries of a county hospital system.
  
  
  METHODS
  Retrospective review of infants with second episodes of GBS bacteremia or meningitis. Digestion of chromosomal DNA with the restriction enzyme Sma I and separation of fragments by use of contour-clamped homogeneous electric field.
  
  
  RESULTS
  Nine cases of recurrent GBS infection were identified during a 14-year period. Eight of the nine infants were born at 25 to 36 weeks of gestation, and one was born at term. The first episode of invasive GBS infection occurred at a mean age of 10.4 days (median, 3 days; range, 1 to 27 days). Parenteral antibiotic therapy was administered for a mean of 13.9 days (median, 14 days; range, 10 to 21 days). Recurrence occurred at a mean age of 42.3 days (median, 48 days; range, 23 to 68 days). One patient died during the second episode; eight infants survived to discharge home. Of seven sets of isolates analyzed from first and second GBS episodes, five were confirmed to be the same genotypically.
  
  
  CONCLUSIONS
  Recurrence of GBS disease in infants may be associated with the original infecting strain or a second acquired strain.
authors.affiliation: Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
authors.forename: P A
authors.initials: PA
authors.lastname: Green
authors.forename: K V
authors.initials: KV
authors.lastname: Singh
authors.forename: B E
authors.initials: BE
authors.lastname: Murray
authors.forename: C J
authors.initials: CJ
authors.lastname: Baker
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D004247:DNA / Q000032:analysis; D004262:DNA Restriction Enzymes / Q000235:genetics; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D010288:Parenteral Nutrition; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D012008:Recurrence; D012189:Retrospective Studies; D013290:Streptococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000235:genetics* / Q000302:isolation & purification; D015996:Survival Rate
chemical_list: D000900:Anti-Bacterial Agents; D004247:DNA; D004262:DNA Restriction Enzymes